2011, Healthcare and Safety - Pharma Rep Focus

Innovating allergy drug delivery with a needle-free alternative

European Pharmaceutical Review

OCTOBER 17, 2024

In the UK, ARS Pharmaceuticals anticipates filing for approval from the Medicines and Healthcare products Regulatory Agency (MHRA) by Q4 2024, under their Mutual Recognition Process A, where MHRA will review and approve EURneffy based on the EMA approval within 60 days of filing. Hand (N Y). 2007; 2(1):5-11.

Food and Drug Administration

Food and Drug Administration Medicine Consulting Food

Why Are Patients So Angry? Plus, Frontliner Tips for Health Leaders

Healthcare Success

JANUARY 25, 2023

But first, we must understand what’s happening in healthcare and the world-at-large post-pandemic. To be clear, workplace violence experienced by healthcare workers predates the pandemic. The rate of injuries from violent attacks against medical professionals grew by 63% from 2011 to 2018.

Patients

Patients Healthcare Healthcare Management

The Caregiver Vertical: How Pharma Engages

Pharma Marketing Network

MARCH 25, 2022

With an estimated 65 million people serving as caregivers, 1 the role is now a factor in an ever-increasing list of healthcare priorities. If caregiving is positioned as an essential service and caregivers are counted among healthcare’s front-line service providers, 4 does it follow caregivers are a viable healthcare vertical?

Pharma

Pharma Education Training Transportation

Botanical drugs – what is the best way forward for regulatory and market approval?

European Pharmaceutical Review

JULY 4, 2024

The FDA’s role in the regulation of botanical drug products includes an assessment of their safety and efficiency 5 but insufficient evidence for efficacy is one of the most common reasons why new drug candidates fail to reach this step. 6 Thus, it is critical to ensure the consistency of therapeutic effect across batches (see box).

Marketing

Marketing Food and Drug Administration Medicine Prescription

Health Innovation Fund, Moderna’s largest shareholder, shares investment strategies

pharmaphorum

AUGUST 22, 2022

Jack Torrance, investment specialist for Baillie Gifford’s Health Innovation Fund, tells us how the organisation ensures its investments will have the most significant positive impact on all stakeholders within the healthcare ecosystem. . The status quo in the healthcare sector is an antiquated and fossilised model, Torrance says.

Healthcare

Healthcare Healthcare Healthcare Provider Specialization

Everything You Need to Know About Market Access in China

PM360

DECEMBER 20, 2023

With its rapidly evolving healthcare system, limited transparency of public information, and language barriers, China has never proven to be an easy market for overseas pharmaceutical companies to enter. In 2021, the out-of-pocket (OOP) cost accounts for 28% of the whole healthcare expenses compared to 15.4% billion people in 2023).

Marketing

Marketing Insurance Medical Manufacturing

Three Steps to Hitting Your MLR Targets in 2021

Clarify Health

AUGUST 26, 2020

Prior to 2011 when the Affordable Care Act (ACA) was passed, many insurance companies were spending a large portion of premium dollars on administrative costs and profits. Implementing best practices designed at improving patient safety. Since the ACA, health plans are required to meet minimum MLR standards.

Insurance

Insurance Medical Networking Management

Paving the way for anti-Abeta active immunotherapy

European Pharmaceutical Review

SEPTEMBER 22, 2023

Active immunotherapy through vaccination has a far lower cost than mAb-based therapies, representing an important decrease of economic burden for healthcare systems at a global scale. 7 It is currently being evaluated in a Phase Ib/IIa clinical study, demonstrating to date a good safety profile.

Food and Drug Administration

Food and Drug Administration Safety Patients Leads

For rare disease patients in Mainland China, hope of greater access to treatment

Clarivate

MAY 24, 2022

The consortium aims to promote awareness for rare diseases within the healthcare community and general public, address the impending issue of drug availability and improve the quality of life of rare disease patients. Gain access to intelligence on Mainland China’s healthcare market and disease-specific trends. 2011; 6:81-82. [3]

Patients

Patients Food and Drug Administration Marketing Pharma

Liron Fendell

Cadensee

JULY 26, 2021

And I was lucky enough the team at Schneider's and Clalit Healthcare , who is the owner of Schneider Hospital. And it also goes to safety, which not surprisingly, was the number one concern with parents. So also want to make sure that our branding and our packaging really communicates the safety of the product.

Retail

Retail Marketing Doctors Food

Private Patient Advocacy: Educating Patients To Be Their Own Advocates With Antra Boyd And Karen DiMarco

Evolve Your Success

MAY 10, 2022

We saw poor outcomes and couldn’t figure out how to change it from within so we thought, “If we can walk alongside a patient and help them navigate the healthcare system, maybe they would have better outcomes.” I spit myself out of the hospital system in 2011. I was done clinical nursing in 2014. Private patient advocacy.

Education

Education Patients Medical sales reps Medical sales

Using RWE in rare disease drug development: effective innovations with historical controls

European Pharmaceutical Review

SEPTEMBER 22, 2022

Additionally, healthcare payers understand that HCs can provide value by describing potential treatment benefit relative to untreated patients in their populations. Healthcare payers also use clinical trial evidence to assess the effectiveness of treatments in making reimbursement decisions. 2011 May; 46(3): 399–424.

Food and Drug Administration

Food and Drug Administration Patients Distribution FDA

Yotam Drechsler & Yaron Segal

Cadensee

OCTOBER 19, 2021

By the way, with a very attractive safety profile so far. And they were looking for some AI-based solutions that can change healthcare dramatically. And hopefully that keeps happening, so we can change health healthcare. Her previous venture PolyTouch Medical was acquired back in 2011. That's great. Yoav Fisher.

Patients

Patients Medical Networking Marketing

Hip Innovation Technology Announces Initiation of FDA Approved Investigational Device Exemption Study

Legacy MEDSearch

JANUARY 13, 2023

The IDE Study is being conducted to determine the safety and effectiveness of the HIT Reverse HRS in Primary Total Hip Arthroplasty (THA). Safety will be assessed through the collection of device-related adverse events and patient quality of life metrics. About Hip Innovation Technology, LLC.

FDA

FDA Safety Recruitment Patients

Pharma Rep Focus

Innovating allergy drug delivery with a needle-free alternative

Why Are Patients So Angry? Plus, Frontliner Tips for Health Leaders

Trending Sources

The Caregiver Vertical: How Pharma Engages

Botanical drugs – what is the best way forward for regulatory and market approval?

Health Innovation Fund, Moderna’s largest shareholder, shares investment strategies

Everything You Need to Know About Market Access in China

Three Steps to Hitting Your MLR Targets in 2021

Paving the way for anti-Abeta active immunotherapy

For rare disease patients in Mainland China, hope of greater access to treatment

Liron Fendell

Private Patient Advocacy: Educating Patients To Be Their Own Advocates With Antra Boyd And Karen DiMarco

Using RWE in rare disease drug development: effective innovations with historical controls

Yotam Drechsler & Yaron Segal

Hip Innovation Technology Announces Initiation of FDA Approved Investigational Device Exemption Study

Stay Connected